Denali Capital extends business combination deadline to June 11, 2025 with $874.78 trust deposit funded by Scilex note

Semnur Pharmaceuticals, Inc.

Deposited $874.78 into trust account to extend deadline from May 11 to June 11, 2025.
Deposit funded by convertible promissory note from Scilex (SCLX) with principal up to $180,000, no interest.
Note convertible at Scilex's discretion into Class A shares at $10.00 per share upon business combination close.
Remaining $57,795.52 available under note expected to fund future one-month extensions if needed.

item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001213900-25-041653
form_type: 8-K
ticker: SMNR
cik: 0001913577
company_name: Semnur Pharmaceuticals, Inc.
filed_at: 2025-05-12T23:59:59+00:00
discovered_at: 2026-05-14T18:02:50.457574+00:00
generated_at: 2026-05-22T00:39:33.719907+00:00
sec_items: ["8.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.5
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001213900-25-041653
json_url: https://secwatch.observer/filing/0001213900-25-041653.json
markdown_url: https://secwatch.observer/filing/0001213900-25-041653.md
text_url: https://secwatch.observer/filing/0001213900-25-041653.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1913577/000121390025041653/0001213900-25-041653-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1913577/000121390025041653/ea0241580-8k425_denali.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001213900-25-041653

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.